Krishna Prasad Chigurupati sold 1.72 crore shares of Granules India Limited for approximately ₹1,564 Cr through the open market. This transaction reduced the promoter's stake in the company from 31.00% to 24.06%.
A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.
